About RIVASHOR 25
RIVASHOR 25, a blue-ribbon anticoagulant, is presented by Cadila Pharmaceuticals and is designed for the imposing management of blood clots. Each first-class, white to off-white oblong tablet contains 25 mg of Rivaroxaban, efficiently indicated for DVT, PE, and stroke prevention in atrial fibrillation. Competitive pricing makes this product highly accessible, but highlighted care must be taken with its prescription-exclusively for adults as directed by a physician. Take advantage of this opportunity-our offer is ending soon! Store securely below 25C, away from sunlight and moisture.
Advanced Application & Features
RIVASHOR 25 stands out with its superior oral anticoagulant plant application, formulated for the prevention and treatment of thromboembolic disorders. Its oblong, easily swallowable tablet form offers patient comfort. The use type is uniquely tailored for adult patients requiring continuous control and management of blood clot-related conditions. The product boasts a 24-month shelf life and is protected within tamper-proof blister strips, ensuring uncompromised efficacy and prolonged stability.
Sample Policy, Packaging & Export Markets
Stock ready for immediate shipment, RIVASHOR 25 follows a customer-friendly sample policy-delivering one strip of 10 tablets for assessment. Expenditure transparency and secure shipping are standard, ensuring the medicine's integrity from warehouse to customer. Packaging details include 10 strips per box using strong blister strips, supporting both retail and bulk needs. Our main export markets include India, Asia, and select international destinations, consistently meeting demand for high-quality prescription medicines worldwide.
FAQ's of RIVASHOR 25:
Q: How should RIVASHOR 25 be taken for optimal efficacy?
A: RIVASHOR 25 tablets are intended for oral administration. Take the tablet whole with water, precisely following your physician's instructions. Do not crush or chew the tablet to ensure maximal effectiveness.
Q: What is the primary benefit of using RIVASHOR 25?
A: RIVASHOR 25 is specially formulated to prevent and treat blood clots, including deep vein thrombosis, pulmonary embolism, and reduce the risk of stroke in patients with atrial fibrillation, providing reliable anticoagulant therapy.
Q: When should RIVASHOR 25 not be used?
A: RIVASHOR 25 should not be used in individuals with active bleeding, severe hepatic impairment, or hypersensitivity to Rivaroxaban or any of its excipients. Always consult your doctor before starting therapy.
Q: What precautions should be observed during usage?
A: Patients must avoid using RIVASHOR 25 if they are prone to or currently have active bleeding or severe liver disorders. Report any side effects such as bleeding, anaemia, gastrointestinal discomfort, or dizziness to your physician immediately.
Q: Where is RIVASHOR 25 manufactured and who markets it?
A: RIVASHOR 25 is manufactured in India and is marketed by Cadila Pharmaceuticals, ensuring international-grade quality and compliance with pharmaceutical standards.
Q: What is the packaging format of RIVASHOR 25?
A: RIVASHOR 25 is packaged in secure blister strips, with each box containing 10 strips of 10 tablets. This packaging protects the tablets from moisture and sunlight, preserving their potency.